Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F18WD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,420
Award facts
- Contract value 100% obligated
- $83,420.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $83,420.15 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of SKYRIZI 150 mg/ml pen (risankizumab), a pharmaceutical product used to treat inflammatory conditions. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company maintains a comprehensive portfolio of pharmaceutical products and medical supplies distributed through the DLA's Medical Supply Chain, which supports customers including the Defense Health Agency and U.S. Coast Guard. The firm's track record demonstrates consistent capability in fulfilling federal procurement requirements through competitive awards, delivering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the federal pharmaceutical supply infrastructure.
Quick answers
Who was awarded contract SPE2DR26F18WD?
SPE2DR26F18WD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F18WD worth?
The government has obligated $83,420 on SPE2DR26F18WD.
Is contract SPE2DR26F18WD an order under another contract?
Yes. SPE2DR26F18WD is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18WD competed?
The extent of competition for SPE2DR26F18WD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award